280 related articles for article (PubMed ID: 12496759)
1. Mutations in NR4A2 associated with familial Parkinson disease.
Le WD; Xu P; Jankovic J; Jiang H; Appel SH; Smith RG; Vassilatis DK
Nat Genet; 2003 Jan; 33(1):85-9. PubMed ID: 12496759
[TBL] [Abstract][Full Text] [Related]
2. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
[TBL] [Abstract][Full Text] [Related]
3. NR4A2 mutations are rare among European patients with familial Parkinson's disease.
Wellenbrock C; Hedrich K; Schäfer N; Kasten M; Jacobs H; Schwinger E; Hagenah J; Pramstaller PP; Vieregge P; Klein C
Ann Neurol; 2003 Sep; 54(3):415. PubMed ID: 12953278
[No Abstract] [Full Text] [Related]
4. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.
Zheng K; Heydari B; Simon DK
Arch Neurol; 2003 May; 60(5):722-5. PubMed ID: 12756136
[TBL] [Abstract][Full Text] [Related]
5. Haplotypes of the NR4A2/NURR1 gene and cardiovascular disease: the Rotterdam Study.
Kardys I; van Tiel CM; de Vries CJ; Pannekoek H; Uitterlinden AG; Hofman A; Witteman JC; de Maat MP
Hum Mutat; 2009 Mar; 30(3):417-23. PubMed ID: 19156841
[TBL] [Abstract][Full Text] [Related]
6. Nr4a2 is essential for the differentiation of dopaminergic neurons during zebrafish embryogenesis.
Luo GR; Chen Y; Li XP; Liu TX; Le WD
Mol Cell Neurosci; 2008 Oct; 39(2):202-10. PubMed ID: 18638558
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Nurr1 nucleotide variations in familial Parkinson's disease.
Levecque C; Destée A; Mouroux V; Amouyel P; Chartier-Harlin MC
Neurosci Lett; 2004 Aug; 366(2):135-8. PubMed ID: 15276233
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease.
Nichols WC; Uniacke SK; Pankratz N; Reed T; Simon DK; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T;
Mov Disord; 2004 Jun; 19(6):649-55. PubMed ID: 15197702
[TBL] [Abstract][Full Text] [Related]
9. Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.
Sánchez-Ferrero E; Coto E; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; Alvarez V
Parkinsonism Relat Disord; 2009 Jul; 15(6):468-70. PubMed ID: 18980857
[TBL] [Abstract][Full Text] [Related]
10. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.
Klein C; Djarmati A; Hedrich K; Schäfer N; Scaglione C; Marchese R; Kock N; Schüle B; Hiller A; Lohnau T; Winkler S; Wiegers K; Hering R; Bauer P; Riess O; Abbruzzese G; Martinelli P; Pramstaller PP
Eur J Hum Genet; 2005 Sep; 13(9):1086-93. PubMed ID: 15970950
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
12. Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease.
Ibáñez P; Lohmann E; Pollak P; Durif F; Tranchant C; Agid Y; Dürr A; Brice A;
Neurology; 2004 Jun; 62(11):2133-4. PubMed ID: 15184637
[No Abstract] [Full Text] [Related]
13. NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain.
Blin M; Norton W; Bally-Cuif L; Vernier P
Mol Cell Neurosci; 2008 Dec; 39(4):592-604. PubMed ID: 18822380
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
15. Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease.
Belin AC; Björk BF; Westerlund M; Galter D; Sydow O; Lind C; Pernold K; Rosvall L; Håkansson A; Winblad B; Nissbrandt H; Graff C; Olson L
Neurosci Lett; 2007 Jun; 420(3):257-62. PubMed ID: 17537576
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R
Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.
Sleiman PM; Healy DG; Muqit MM; Yang YX; Van Der Brug M; Holton JL; Revesz T; Quinn NP; Bhatia K; Diss JK; Lees AJ; Cookson MR; Latchman DS; Wood NW
Neurosci Lett; 2009 Jun; 457(2):75-9. PubMed ID: 19429166
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of NR2E3 and NRL genes in Enhanced S Cone Syndrome.
Wright AF; Reddick AC; Schwartz SB; Ferguson JS; Aleman TS; Kellner U; Jurklies B; Schuster A; Zrenner E; Wissinger B; Lennon A; Shu X; Cideciyan AV; Stone EM; Jacobson SG; Swaroop A
Hum Mutat; 2004 Nov; 24(5):439. PubMed ID: 15459973
[TBL] [Abstract][Full Text] [Related]
20. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
